Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 16

Showing 16 citing articles:

SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Brittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 6, pp. e581-e593
Closed Access | Times Cited: 12
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Biophysics of SARS-CoV-2 spike protein’s receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights
Fernando Luís Barroso da Silva, Karen Paco, Aatto Laaksonen, et al.
Biophysical Reviews (2025)
Closed Access
Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV
Xiaoqing Guan, Abhishek Kumar Verma, Qian Liu, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 293-293
Open Access
Advances in virus-like particle-based SARS-CoV-2 vaccines
Xiaoting Hao, Feifei Yuan, Xuan Yao
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects
Jonathan F. Lovell, Kazutoyo Miura, Yeong Ok Baik, et al.
International Journal of Infectious Diseases (2023) Vol. 138, pp. 73-80
Open Access | Times Cited: 11
Project NextGen: Developing the Next Generation of Coronavirus Disease 2019 (COVID-19) Vaccines and Therapeutics to Respond to the Present and Prepare for the Future
Kimberly A. Hofmeyer, Christy L. Ventura, Kimberly L. Armstrong, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 1, pp. 115-121
Open Access | Times Cited: 3
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 2
Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin
Kasidy R. Gossen, Meiyi Zhang, Z̆ivko L. Nikolov, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Augmenting vaccine efficacy: Tailored immune strategy with alum-stabilized Pickering emulsion
Tiantian Song, Fengqiang Cao, Xiaonan Huang, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126022-126022
Closed Access | Times Cited: 1
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Gang Wang, Abhishek Kumar Verma, Juan Shi, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge
Gang Wang, Abhishek Kumar Verma, Xiao‐Qing Guan, et al.
Journal of Virology (2024) Vol. 98, Iss. 9
Closed Access | Times Cited: 1
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
Xiao‐Qing Guan, Abhishek Kumar Verma, Gang Wang, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 108033-108033
Open Access | Times Cited: 4
The impact of N-glycans on the immune response of plant-produced SARS-CoV-2 RBD-Fc proteins
Theerakarn Srisangsung, Thareeya Phetphoung, Suwimon Manopwisedjaroen, et al.
Biotechnology Reports (2024) Vol. 43, pp. e00847-e00847
Open Access
Current Advances in Viral Nanoparticles for Biomedicine
Xianxun Sun, Tao Tian, Yindong Lian, et al.
ACS Nano (2024)
Closed Access
Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-CoV-2 and its variants
Berenice Calderón-Pérez, Leandro Alberto Núñez-Muñoz, Lady Laura Trejo-Ayala, et al.
Virology (2024) Vol. 603, pp. 110380-110380
Closed Access
Novel polymer-based hydrogels of recent research in drug delivery for disease treatment related to SARS-CoV-2 virus
Hoc Thang Nguyen, Van Phuc Nguyen, Tran Thi Tu Nhi, et al.
eXPRESS Polymer Letters (2023) Vol. 18, Iss. 2, pp. 160-192
Open Access | Times Cited: 1
Transient Expression in HEK-293 Cells in Suspension Culture as a Rapid and Powerful Tool: SARS-CoV-2 N and Chimeric SARS-CoV-2N-CD154 Proteins as a Case Study
Thailin Lao, Omar Farnós, Alexi Bueno, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3050-3050
Open Access
Page 1

Scroll to top